Pharmacology and Toxicology Department Highlights: July 2026

Publications

Diagnostic exogenous probe strategy using ezetimibe-glucuronide effectively identifies metabolic dysfunction-associated steatohepatitis.
Farrera DO, Frost KL, Jilek JL, Sample PA, Izu JM, Alaaldin MM, Lindberg P, Maloney MM, Rodrigues D, Yamaguchi E, Ryu S, Bi YA, West M, Mathialagan S, Lazzaro S, Rabe B, Nguyen AP, Ho K, Messenger S, Rahimi AO, Akhbari R, Säll C, Klimecki W, Paine MF, Wright SH, Billheimer D, Block G, Ghaderi I, Cherrington NJ. Drug Metab Dispos. 2026 Jun 29;54(8):100351. doi: 10.1016/j.dmd.2026.100351. Online ahead of print. PMID: 42531743
 

Hongmin Li
Singh V, Gao Z, Li Z, Li H (2026), Biochemical characterization and assay development for adenylosuccinate synthetase Rv0357c from Mycobacterium tuberculosis, BBA – Proteins and Proteomics, https://doi.org/10.1016/j.bbapap.2026.141167

Weiguo Han, Qing-Yu Zhang, Xinxin Ding
Xiangmeng Wu, Weiguo Han, Lei Yin, Weizhu Yang, Jonathan Sheng, John Han, Robert J. Turesky, Laura S. Van Winkle, Qing-Yu Zhang, Xinxin Ding, Generation and characterization of a serum albumin-humanized mouse model and its utility for detection of albumin adduct formation in vivo, Drug Metabolism and Disposition, Volume 54, Issue 8, 2026